Skip to main content
. 2011 May 19;118(3):535–543. doi: 10.1182/blood-2011-02-334755

Figure 2.

Figure 2

Response rates in the non-ASCT and ASCT groups of patients. For simplicity, CR and nCR rates were combined. In the non-ASCT group, the CR rate was 8.6% and at best response 26%, including 4% sCR, at 4 cycles. In the ASCT group, the CR rate was 22% and after ASCT 37%, including 22% sCR, at 4 cycles.